These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 10947729)

  • 1. Suspected acute post-transplant neuropsychosis due to interaction of morphine and cyclosporin after a renal transplant.
    Lee PC; Hung CJ; Lei HY; Tsai YC
    Anaesthesia; 2000 Aug; 55(8):827-8. PubMed ID: 10947729
    [No Abstract]   [Full Text] [Related]  

  • 2. Hyperbilirubinemia in a renal transplant patient due to cyclosporin A therapy.
    Ertörer ME; Paydaş S; Sagliker Y
    Nephron; 1997; 76(3):368. PubMed ID: 9226250
    [No Abstract]   [Full Text] [Related]  

  • 3. Interactions of cyclosporin A and amlodipine: blood cyclosporin A levels, hypertension and kidney function.
    Schrama YC; Koomans HA
    J Hypertens Suppl; 1998 Sep; 16(4):S33-8. PubMed ID: 9817190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclosporin drug-interaction-induced rhabdomyolysis. A report of two cases in lung transplant recipients.
    Cohen E; Kramer MR; Maoz C; Ben-Dayan D; Garty M
    Transplantation; 2000 Jul; 70(1):119-22. PubMed ID: 10919586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cyclosporin A, renal transplant and hepatocarcinoma].
    Indart A; García Bengoechea M; Arenas JI
    Gastroenterol Hepatol; 2000 Dec; 23(10):498. PubMed ID: 11149227
    [No Abstract]   [Full Text] [Related]  

  • 6. Acute toxic myopathy due to pyrazinamide in a patient with renal transplantation and cyclosporine therapy.
    Fernández-Solà J; Campistol JM; Miró O; Garcés N; Soy D; Grau JM
    Nephrol Dial Transplant; 1996 Sep; 11(9):1850-2. PubMed ID: 8918638
    [No Abstract]   [Full Text] [Related]  

  • 7. Kidney transplant recipients and the incidence of adverse reactions to cyclosporin.
    Tolou-Ghamari Z; Palizban AA
    Saudi Med J; 2004 Oct; 25(10):1499-500. PubMed ID: 15494834
    [No Abstract]   [Full Text] [Related]  

  • 8. Cyclosporin A-related Raynaud's phenomenon in a renal transplant recipient.
    Sharma AK; Sunil S; Rustom R; Bone JM; Hammad A; Bakran A; Sells RA
    Transpl Int; 2002 Oct; 15(9-10):517-8. PubMed ID: 12389086
    [No Abstract]   [Full Text] [Related]  

  • 9. Severe colchicine intoxication in a renal transplant recipient on cyclosporine.
    Garrouste C; Philipponnet C; Kaysi S; Enache I; Tiple A; Heng AE
    Transplant Proc; 2012 Nov; 44(9):2851-2. PubMed ID: 23146540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychosis After Switch in Opioid Maintenance Agonist and Risperidone-Induced Pisa Syndrome: Two Critical Incidents in Dual Diagnosis Treatment.
    Sutter M; Walter M; Dürsteler KM; Strasser J; Vogel M
    J Dual Diagn; 2017; 13(2):157-165. PubMed ID: 27935442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Interaction of cyclosporin with CSE inhibitors].
    Martini B
    Med Monatsschr Pharm; 2006 Oct; 29(10):379. PubMed ID: 17058898
    [No Abstract]   [Full Text] [Related]  

  • 12. Long-term follow-up after conversion from tacrolimus to cyclosporin in renal transplant patients with new-onset diabetes mellitus after transplantation.
    Batista F; Auyanet I; Torregrosa JV; Oppenheimer F
    Transplant Proc; 2012 Nov; 44(9):2582-4. PubMed ID: 23146461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Statins' dosage in patients with renal failure and cyclosporine drug-drug interactions in transplant recipient patients.
    Launay-Vacher V; Izzedine H; Deray G
    Int J Cardiol; 2005 May; 101(1):9-17. PubMed ID: 15860377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of the new immunosuppressive agents on the occurrence of malignancies after renal transplantation.
    Marcén R; Galeano C; Fernández-Rodriguez A; Jiménez-Alvaro S; Teruel JL; Rivera M; Burgos FJ; Quereda C
    Transplant Proc; 2010 Oct; 42(8):3055-7. PubMed ID: 20970609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Haemolytic uraemic syndrome (HUS) during treatment with cyclosporin A after renal transplantation--is tacrolimus the answer?
    Grupp C; Schmidt F; Braun F; Lorf T; Ringe B; Müller GA
    Nephrol Dial Transplant; 1998 Jul; 13(7):1629-31. PubMed ID: 9681701
    [No Abstract]   [Full Text] [Related]  

  • 16. Managing psychosis in a renal transplant recipient with bipolar affective disorder and allograft rejection.
    Dave V; Mulley W; Kanellis J; Summers S
    Nephrology (Carlton); 2015 Mar; 20 Suppl 1():2-5. PubMed ID: 25807849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal transplant-associated hyperuricemia and gout.
    Clive DM
    J Am Soc Nephrol; 2000 May; 11(5):974-979. PubMed ID: 10770978
    [No Abstract]   [Full Text] [Related]  

  • 18. Reversible acute renal failure caused by the combined use of foscarnet and cyclosporin in organ transplanted patients.
    Morales JM; Muñoz MA; Fernández Zataraín G; García Cantón C; García Rubiales MA; Andrés A; Aguado JM; Gonzalez Pinto I
    Nephrol Dial Transplant; 1995; 10(6):882-3. PubMed ID: 7566623
    [No Abstract]   [Full Text] [Related]  

  • 19. Drug points. Probable interaction between cyclosporin A and low dose ticlopidine.
    Verdejo A; de Cos MA; Zubimendi JA; López-Lázaro L
    BMJ; 2000 Apr; 320(7241):1037. PubMed ID: 10764363
    [No Abstract]   [Full Text] [Related]  

  • 20. Kidney graft dysfunction after drug interaction between miocamycin and cyclosporin.
    Treille S; Quoidbach A; Demol H; Juvenois A; Dehout F; Abramowicz D
    Transpl Int; 1999; 12(2):157. PubMed ID: 10363601
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.